NIAID Funding News, May 4, 2022

May 4, 2022 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  A Deep Dive Into Data Management and Sharing NIH's new policy requires effective data management with the development of data management and sharing plans as well as maximum data sharing in a timely manner. Opportunities and Resources Undertake Limited Interaction Targeted Epidemiology for Viral Suppression Propose to establish a large digitally-maintained cohort of 1,000 participants or more to prospectively investigate trajectories of HIV care engagement and viral suppression. Seek SEPA Funding To Educate Grades 12 and Below The Science Education Partnership Award (SEPA) initiative supports skills development, research experiences, mentoring, curriculum or methods development, and outreach for younger students. NIAID Contract Opportunity To Develop a Novel Vaccine Adjuvant NIAID will support the preclinical development of lead adjuvants for use in vaccines to prevent or treat human disease caused by non-HIV infectious pathogens or immune-mediated diseases. In The News iEdison Transitioning to NIST This Summer The system award recipients use to report inventions and patents resulting from federal research will move from NIH's eRA to the National Institute of Standards and Technology (NIST). Explore a New Look for eRA's Website Although the website has a new homepage layout and labels some sections differently, rest assured that eRA's guidance for applicants, grantees, and reviewers remains unchanged. Advice Corner Changing Institutions? Know What To Do First If you plan to change institutions, plan well ahead for your ongoing award's corresponding transfer, not after you have moved to the new institution or just before your project ends. Reader Questions "How much is NIH's annual stipend for a postdoc with a fellowship award?" "Am I required to apply in English, or can I use another language to write my application?" New Funding Opportunities NOT-AI-22-048, Notice of Special Interest (NOSI)—Administrative Supplements for Lyme Disease and Other Tickborne Illnesses NOT-AI-22-043, Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection NOT-CA-22-063, Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy NOT-AI-22-042, Notice of Special Interest (NOSI)—Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, May 4, 2022 — Add Comment